What changed in this filing

/stocks — the workspaceLOADING

Item 2. Unregistered Sales of Equity Securities

2022-03-16 compared with 2021-09-14 · 22 added, 14 removed, 4 unchanged (90% of the section changed)

Unregistered Sales of Equity Securities and Use of Proceeds

issued the following securities during the three months ended July 31, 2021 and through the date of this Quarterly Report on Form 10-Q:

May 2021, the Company sold an aggregate of 2,087,822 shares of common stock to eight “accredited

investors” at $0.13 per share for an aggregate purchase price of $286,250.

Sales of Equity Securities and Use of Proceeds

We issued the following securities during the three

months ended January 31, 2022 and through the date of this Quarterly Report on Form 10-Q:

November 2021, the Company sold an aggregate of 8,000,000 shares of common stock to one “accredited

investor” at $0.05 per share for an aggregate purchase price of $400,000.

were used for working capital.

the period June 2021 through July 2021, the Company sold an aggregate of 11,541,500 shares

of common stock to four “accredited investors” at prices ranging from $0.05 per

share to $0.13 per share for an aggregate purchase price of $631,020.

The proceeds were used

for working capital.

August 2021, the Company sold an aggregate of 3,000,000 shares of common stock to one “accredited

January 2022, the Company sold an aggregate of 666,667 shares of common stock to one “accredited

investor” at $0.03 per share for an aggregate purchase price of $20,000.

price was paid through an offset of an outstanding balance owed by the Company to the investor

at the time of the sale of $20,000.

January 11, 2022, the Company entered into a Securities Purchase Agreement with AJB Capital

Investments, LLC (the “Purchaser”) pursuant to which we sold a Promissory Note

in the principal amount of $600,000 to the Purchaser in a private transaction for a purchase

price of $540,000 (giving effect to original issue discount of $60,000).

The proceeds were

used for working capital.

February 2022, the Company sold an aggregate of 8,333,333 shares of common stock to one “accredited

investor” at $0.03 per share for an aggregate purchase price of $250,000.

were used for working capital.

of the above issuances involved any underwriters, underwriting discounts or commissions, or any public offering and we believe were exempt

from the registration requirements of the Securities Act by virtue of Section 4(a)(2) and Regulation D promulgated thereunder due to

the fact that there was no solicitation or advertising and the did not involve a public offering of securities.

None of the above issuances involved any underwriters,

underwriting discounts or commissions, or any public offering and we believe were exempt from the registration requirements of the Securities

Act by virtue of Section 4(a)(2) and Regulation D promulgated thereunder due to the fact that there was no solicitation or advertising

and the did not involve a public offering of securities.

Defaults upon Senior Securities

Mine Safety Disclosures

Safety Disclosures

Not applicable.

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Unregistered Sales of Equity Securities